(Q41855495)

English

Comparison of the bactericidal activity of clindamycin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group

scientific article published on September 1, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 October 2017

Comparison of the bactericidal activity of clindamycin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group (English)

1 reference

10.1016/0732-8893(91)90064-M

https://api.crossref.org/works/10.1016/0732-8893(91)90064-M

28 November 2022

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Bacteroides fragilis

object named as

Bacteroides fragilis

1 reference

based on heuristic

inferred from title

author name string

C. W. Stratton

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1797454

28 November 2022

L. S. Weeks

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1797454

28 November 2022

K. E. Aldridge

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1797454

28 November 2022

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 September 1991

1 reference

Europe PubMed Central

PubMed publication ID

13 October 2017

full work available at URL

https://api.elsevier.com/content/article/PII:073288939190064M?httpAccept=text/xml

1 reference

10.1016/0732-8893(91)90064-M

https://api.crossref.org/works/10.1016/0732-8893(91)90064-M

28 November 2022

https://api.elsevier.com/content/article/PII:073288939190064M?httpAccept=text/plain

1 reference

10.1016/0732-8893(91)90064-M

https://api.crossref.org/works/10.1016/0732-8893(91)90064-M

28 November 2022

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

13 October 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

13 October 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

13 October 2017

377-382

1 reference

Europe PubMed Central

PubMed publication ID

13 October 2017

Antibiotic- and method-dependent variation in susceptibility testing results of Bacteroides fragilis group isolates

3

1 reference

10.1016/0732-8893(91)90064-M

https://api.crossref.org/works/10.1016/0732-8893(91)90064-M

28 November 2022

Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology

4

1 reference

10.1016/0732-8893(91)90064-M

https://api.crossref.org/works/10.1016/0732-8893(91)90064-M

28 November 2022

Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents

5

1 reference

10.1016/0732-8893(91)90064-M

https://api.crossref.org/works/10.1016/0732-8893(91)90064-M

28 November 2022

Bacteroides fragilis endocarditis, bacteremia and other infections treated with oral or intravenous metronidazole

7

1 reference

10.1016/0732-8893(91)90064-M

https://api.crossref.org/works/10.1016/0732-8893(91)90064-M

28 November 2022

Bacteroides fragilis resistant to both metronidazole and imipenem.

9

1 reference

10.1016/0732-8893(91)90064-M

https://api.crossref.org/works/10.1016/0732-8893(91)90064-M

28 November 2022

The estimation of the bactericidal power of the blood

10

1 reference

10.1016/0732-8893(91)90064-M

https://api.crossref.org/works/10.1016/0732-8893(91)90064-M

28 November 2022

Increasing incidence of clinical isolates of Bacteroides fragilis resistant to clindamycin

13

1 reference

10.1016/0732-8893(91)90064-M

https://api.crossref.org/works/10.1016/0732-8893(91)90064-M

28 November 2022

Bacteroides fragilis resistance to clindamycin in vitro

14

1 reference

10.1016/0732-8893(91)90064-M

https://api.crossref.org/works/10.1016/0732-8893(91)90064-M

28 November 2022

Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs.

16

1 reference

10.1016/0732-8893(91)90064-M

https://api.crossref.org/works/10.1016/0732-8893(91)90064-M

28 November 2022

Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States

17

1 reference

10.1016/0732-8893(91)90064-M

https://api.crossref.org/works/10.1016/0732-8893(91)90064-M

28 November 2022

Identifiers

10.1016/0732-8893(91)90064-M

1 reference

Europe PubMed Central

PubMed publication ID

13 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41855495&oldid=2130852333"